Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Olink Proteomics Acquires Antibody Maker Agrisera

Olink Proteomics Acquires Antibody Maker Agrisera

May 12, 2020
|
staff reporter

NEW YORK — Olink Proteomics said on Tuesday that it has acquired Swedish antibody manufacturer Agrisera.

Terms of the transaction were not disclosed.

Olink offers protein biomarker discovery products and services based on its proximity extension assay technology, which uses oligonucleotide-labeled antibodies to enable multiplex protein measurement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Up to Him

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

Study of Racism in Academic Research

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

Kodak Loan on Pause

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

Cell Studies on Blood Immune Features in Severe COVID-19 Cases, Alzheimer's Spatial Transcriptomes

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.

Sep
09
Featured Webinar

Spatially Resolved Transcriptomics: The Landscape of Tools for Spatial Gene Expression

Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems. 

What's Popular?

In Proteomics & Protein Research

  1. ImmunoScape Using $11M Funding Round to Establish US Operations

    Premium

  2. Utrecht University, Bruker Collaborating on TimsTOF Methods for Crosslinking Mass Spec

    Premium

  3. Fluidigm Q2 Revenues Fall 8 Percent but Beat Analysts' Estimates

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.